Serial 79108413
Live / Registered — International registration cancelled — extension of protection cancelled (as of 04 Jan 2022)
What this means for you
Registered since 02 Apr 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79108413
- Registration number
- 4311029
- Mark type
- Design / logo
- Filed
- 03 Jan 2012
- Published for opposition
- 15 Jan 2013
- Registered
- 02 Apr 2013
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purpose, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Capsules for pharmaceutical purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Raw material drug, namely, active pharmaceutical ingredients which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chinese medicine nostrum, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, beverages or food which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Additives to fodder for medical use; Medicines for veterinary purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases,for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases for use in veterinary
Owner
Prosecution history
- 23 Jul 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 23 Jul 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 12 Sept 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
- 16 Aug 2020 — GENERIC MADRID TRANSACTION SENT TO IB
- 15 Aug 2020 — GENERIC MADRID TRANSACTION CREATED
- 08 Jul 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 08 Nov 2019 — CANCELLED SECTION 71
- 08 Oct 2019 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 05 Jul 2019 — CORRECTION TRANSACTION RECEIVED FROM IB
- 04 Jul 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Dec 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Aug 2014 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Jul 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 03 Jul 2013 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 Jul 2013 — FINAL DISPOSITION PROCESSED